1. bookVolume 26 (2018): Issue 2 (April 2018)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Effects of miR-99a on the migration and proliferation of glioma cells

Published Online: 17 May 2018
Page range: 145 - 152
Received: 21 Aug 2017
Accepted: 10 Jan 2018
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Background To evaluate the effects of miR-99a on the migration and proliferation of glioma cells. Materials and Methods: Glioma cell line LN229 with stable up-regulation of miR-99a was constructed by transfection of hsa-miR-99a mimics, and cells with stable miR-99a knock-down were established by transfection of hsa-miR-99a inhibitor. The proliferation capacities of two groups were detected by the MTT assay, and their migration capacities were detected by the scratch assay. Results: LN229 cells with stable up-regulation and knock-down of miR-99a were successfully constructed. Up-regulating miR-99a inhibited the proliferation and migration of glioma cells, but knocking down this gene promoted their proliferation and migration. Conclusion: MiR-99a significantly affected the proliferation and migration of glioma cells, as a potentially eligible target for glioma therapy.

Keywords

1. Ma CC, Xiong Z, Zhu GN, Wang C, Zong G, Wang HL, et al. Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a. J Exp Clin Cancer Res. 2016;35(1):90. DOI: 10.1186/s13046-016-0367-210.1186/s13046-016-0367-2489588827267902Open DOISearch in Google Scholar

2. Cui B, Li B, Liu Q, Cui Y. lncRNA CCAT1 promotes glioma tumorigenesis by sponging miR-181b. J Cell Biochem. 2017;118(12):4548-57. DOI: 10.1002/jcb.2611610.1002/jcb.2611628475287Open DOISearch in Google Scholar

3. Yin D, He X, Zhang E, Kong R, De W, Zhang Z. Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol. 2014;31(11):253. DOI: 10.1007/s12032-014-0253-810.1007/s12032-014-0253-825326054Open DOISearch in Google Scholar

4. Chen C, Zhao Z, Liu Y, Mu D. microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells. Oncol Lett. 2015;9(3):1128-34. DOI: 10.3892/ol.2015.287310.3892/ol.2015.2873431502125663868Open DOISearch in Google Scholar

5. Zhang J, Jin H, Liu H, Lv S, Wang B, Wang R, et al. MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma. Oncogenesis. 2014;3:e97. DOI: 10.1038/oncsis.2014.1110.1038/oncsis.2014.11400719324732044Open DOISearch in Google Scholar

6. Feng Y, Kang Y, He Y, Liu J, Liang B, Yang P, et al. microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer. BMC Urol 2014;14(1):50. DOI: 10.1186/1471-2490-14-5010.1186/1471-2490-14-50408387224957100Open DOISearch in Google Scholar

7. Sun M, Hong S, Li W, Wang P, You J, Zhang X, et al. miR-99a regulates ROS-mediated invasion and migration of lung adenocarcinoma cells by targeting NOX4. Oncol Rep. 2016;35(5):2755-66. DOI: 10.3892/or.2016.467210.3892/or.2016.467226986073Open DOISearch in Google Scholar

8. Hao B, Cui L, Gu Y, Zhang B, Wang M, Zhou H, et al. MiR-99A Suppresses Proliferation, Migration, Invasion and Induces G1-Phase Cell Cycle Arrest via Targeting IGF-1R Pathway in Renal Cell Carcinoma 786-0 and OS-RC-2 Cells. Urology. 2017;doi: 10.1016/j.urology. 2017.01.003. DOI: 10.1016/j.urology.2017.01.003Search in Google Scholar

9. Parker BC, Annala MJ, Cogdell DE, Granberg KJ, Sun Y, Ji P, et al. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. J Clin Invest. 2013;123(2):855-65. DOI: 10.1172/JCI6714410.1172/JCI67144356183823298836Open DOISearch in Google Scholar

10. Barbagallo D, Condorelli A, Ragusa M, Salito L, Sammito M, Banelli B, et al. Dysregulated miR-671-5p/ CDR1-AS/CDR1/VSNL1 axis is involved in glioblastoma multiforme. Oncotarget. 2016;7(4):4746-59. DOI: 10.18632/oncotarget.662110.18632/oncotarget.6621482624026683098Search in Google Scholar

11. Li X, Liu Y, Granberg KJ, Wang Q, Moore LM, Ji P, et al. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 2015;34(13):1619-28. DOI: 10.1038/onc.2014.9810.1038/onc.2014.98420522724747968Open DOISearch in Google Scholar

12. Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard JL, Bauchet L, et al. Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases. J Neurosurg. 2013;118(6):1157-68. DOI: 10.3171/2013.1.JNS12110.3171/2013.1.JNS12123495881Open DOISearch in Google Scholar

13. Chen YS, Chen ZP. Vasculogenic mimicry: a novel target for glioma therapy. Chin J Cancer. 2014;33(2):74-9. DOI: 10.5732/cjc.012.1029210.5732/cjc.012.10292393500823816560Open DOISearch in Google Scholar

14. Wang XJ, Xiang BY, Ding YH, Chen L, Zou H, Mou XZ, et al. Human menstrual blood-derived mesenchymal stem cells as a cellular vehicle for malignant glioma gene therapy. Oncotarget. 2017;8(35):58309-21. DOI: 10.18632/oncotarget.1762110.18632/oncotarget.17621560165428938558Search in Google Scholar

15. Portnow J, Synold TW, Badie B, Tirughana R, Lacey SF, D’Apuzzo M, et al. Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients. Clin Cancer Res. 2017;23(12):2951-60. DOI: 10.1158/1078-0432.CCR-16-151810.1158/1078-0432.CCR-16-1518884377827979915Open DOISearch in Google Scholar

16. Palumbo S, Miracco C, Pirtoli L, Comincini S. Emerging roles of microRNA in modulating celldeath processes in malignant glioma. J Cell Physiol. 2014;229(3):277-86. DOI: 10.1002/jcp.2444610.1002/jcp.2444623929496Open DOISearch in Google Scholar

17. Gerresheim GK, Dünnes N, Nieder-Röhrmann A, Shalamova LA, Fricke M, Hofacker I, et al. microRNA- 122 target sites in the hepatitis C virus RNA NS5B coding region and 3’ untranslated region: function in replication and influence of RNA secondary structure. Cell Mol Life Sci. 2017;74(4):747-60. DOI: 10.1007/s00018-016-2377-910.1007/s00018-016-2377-927677491Open DOISearch in Google Scholar

18. Yu SH, Zhang CL, Dong FS, Zhang YM. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway. J Cell Biochem. 2015;116(2):268-76. DOI: 10.1002/jcb.2496510.1002/jcb.2496525187230Open DOISearch in Google Scholar

19. Feliciano A, Garcia-Mayea Y, Jubierre L, Mir C, Hummel M, Castellvi J, et al. miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer. Cell Death Dis. 2017;8(10):e3141. DOI: 10.1038/cddis.2017.54410.1038/cddis.2017.544568091329072692Open DOISearch in Google Scholar

20. Modi BP, Washington S, Walsh SW, Jackson-Cook C, Archer KJ, Strauss JF 3rd. Expression patterns of the chromosome 21 MicroRNA cluster (miR-99a, miR- 125b and let-7c) in chorioamniotic membranes. Placenta. 2017;49:1-9. DOI: 10.1016/j.placenta.2016.11.00210.1016/j.placenta.2016.11.002550278628012448Open DOISearch in Google Scholar

21. Cheng H, Xue J, Yang S, Chen Y, Wang Y, Zhu Y, et al. Co-targeting of IGF1R/mTOR pathway by miR- 497 and miR-99a impairs hepatocellular carcinoma development. Oncotarget. 2017;8(29):47984-97. DOI: 10.18632/oncotarget.1820710.18632/oncotarget.18207556462028624790Search in Google Scholar

22. Mei LL, Qiu YT, Huang MB, Wang WJ, Bai J, Shi ZZ. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway. Cancer Biomark. 2017;doi: 10.3233/CBM-170345. DOI: 10.3233/CBM-170345Search in Google Scholar

23. Zhang M, Guo Y, Wu J, Chen F, Dai Z, Fan S, et al. Roles of microrna-99 family in human glioma. Onco Targets Ther. 2016;9:3613-9.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo